No Matches Found


Loading...
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

Jiangsu Sihuan Bioengineering Hits Day Low Amid Price Pressure at CNY 3.54

Jiangsu Sihuan Bioengineering Co., Ltd. saw a notable stock decline today, contrasting with a slight increase in the China Shanghai Composite. While the company reported significant growth in net sales for the first half of the year, it also faced long-term profitability challenges, including a net loss.

May 29 2026 04:58 PM IST
share
Share Via
Jiangsu Sihuan Bioengineering Hits Day Low Amid Price Pressure at CNY 3.54

Jiangsu Sihuan Bioengineering Hits Day High with 9.93% Surge

Jiangsu Sihuan Bioengineering Co., Ltd. saw a notable stock price increase on May 25, 2026, contrasting with the broader market. The company reported a 62.31% rise in net sales for the recent half-year, although it faces challenges like low return on capital and declining net profit.

May 26 2026 04:08 PM IST
share
Share Via
Jiangsu Sihuan Bioengineering Hits Day High with 9.93% Surge

Jiangsu Sihuan Bioengineering Hits Day High with 10.13% Surge

Jiangsu Sihuan Bioengineering Co. has seen a significant rise in its stock price, driven by a 62.31% increase in net sales, totaling CNY 131.18 million for the half-year. Despite strong cash flow and impressive annual returns, the company struggles with a low return on capital and a net loss.

May 25 2026 05:18 PM IST
share
Share Via
Jiangsu Sihuan Bioengineering Hits Day High with 10.13% Surge

Jiangsu Sihuan Bioengineering Co., Ltd. Faces Challenges Amidst Financial Performance Decline

Jiangsu Sihuan Bioengineering Co., Ltd. has reported disappointing financial results for the quarter ending March 2025, raising investor concerns. However, the company maintains a strong Debtors Turnover Ratio of 2.69%, indicating effective receivables management. Stakeholders are closely monitoring its strategies for recovery and future growth amid sector volatility.

Sep 03 2025 04:39 PM IST
share
Share Via

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read